1 / 17

Needle and syringe programmes

Needle and syringe programmes. Implementing NICE guidance. 2009. NICE public health guidance 18. What this presentation covers. Background Scope Recommendations Discussion Find out more. Background. 115,000 - 200,000 injecting drug users (IDUs) in England

hien
Télécharger la présentation

Needle and syringe programmes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18

  2. What this presentation covers • Background • Scope • Recommendations • Discussion • Find out more

  3. Background • 115,000 - 200,000 injecting drug users (IDUs) in England • 23% of IDUs report recently sharing needles • Over 40% of IDUs are Hepatitis C positive • IDUs are ten times more likely to die prematurely than the rest of the population • In 2006, over 1400 deaths were linked to controlled drugs

  4. Scope • The optimal provision of needle exchange and syringe programmes (NSPs) for people who injectillicit substances and non-prescribed anabolic steroids • Majority of NSPs are run by pharmacies and drug services • Some NSPs offer other services such as help to stoptaking drugs • This guidance refers to people of 18 years and older

  5. Planning, needs assessment and community engagement LSPs, PCTs and D(A)ATS should collect and analyse localdata on: • problems/harms linked to injecting drug use e.g. infections • number and characteristics of people who inject • number of IDUs in regular contact an NSP • number who have sterile injecting equipment available

  6. Planning, needs assessment and community engagement LSPs, PCTs and D(A)ATS should • Use data gathered to ensure services meet local need • Consult people who inject drugs when planning NSPs • Consult local communities • Use the information collated to ensure NSP services meet local need • During consultations with local communities:- promote the benefits of the service- actively involve communities

  7. Meeting need LSPs, PCTs and D(A)ATS should commission generic and targeted services to: • increase the number of people who have more than one sterile syringe and needle available per injection • reach more people from specific groups who inject • offer advice, information and referral to harm reduction services

  8. Meeting need LSPs, PCTs and D(A)ATS should • Develop needle and syringe disposal plans • Encourage needle and syringe identification schemes • Commission integrated care for people who inject drugs • Audit and monitor services

  9. Types of service LSPs, PCTs and D(A)ATS should - use pharmacies, specialist NSPs and other settings to provide a balanced mix of services: • Level one - injecting equipment (loose or in packs) with written information on harm reduction • Level two - bespoke equipment plus harm reduction and health promotion advice • Level three - bespoke equipment, harmreduction advice plus specialist services

  10. Types of service LSPs, PCTs and D(A)ATS should • Ensure injecting equipment is available for a significant time during any 24-hour period • Consider using community pharmacies that operate extended opening hours • Ensure opioid substitution services also offer needles and syringes

  11. Equipment and advice • Needle and syringe programme providersshould provide people who inject drugs with • needles, syringes and other injecting equipment • at quantity based on need, not subject to arbitrary limit • where possible, in a range of sizes • including sharps bins and advice on safer disposal • safer injecting advice when providing long needles

  12. Equipment and advice • Needle and syringe programme providers should • encourage people who inject drugs to: • use syringe identification methods • use harm reduction services • stop using drugs or to switch to non-injecting methods • address their other health needs • advise where these services can be accessed

  13. Community pharmacy NSP • Provide sharps bins, advice on safer disposal • Provide a service for safe disposal of used equipment • Ensure Hepatitis B vaccination is available for staff • Ensure staff can provide signposting and referral to local agencies offering further support

  14. Community pharmacy NSP Training • Staff should be trained for the level of service they offer • Staff should receive health and safety training • For level 2 or 3 services, staff should be trained to provide health promotion advice • Training should also incorporate how to treat controlled drug using clients in a non-stigmatising way

  15. Specialist NSPs • Provide a selection of individual needles, syringes and other injecting equipment • Offer harm-reduction services including: - safer injecting and overdose prevention advice - help to stop injecting drugs - and referral to opioid substitution therapy (OST) • Offer (or refer to) specialist services including, OST, vaccinations, wound care and welfare and advocacy

  16. Discussion • How can we engage NSP clients in service planning consultations? • What is the profile of our NSP clients? • Are we also meeting the needs of people who inject stimulants? • How are we dealing with drug-related litter? • How can we monitor the training and competencies of staff working for commissioned services?

  17. Find out more • Visit www.nice.org.uk/PH18 for the: • guidance • quick reference guide • Costing statement and costing template • audit support • local authority planning checklist • factsheet for commissioners

More Related